Astaxanthin Prevents Dysregulation of Mitochondrial Dynamics in Rat Brain Mitochondria Induced under Isoproterenol-Induced Injury
- Авторлар: Krestinin R.1, Baburina Y.1, Odinokova I.1, Sotnikova L.1, Krestinina О.1
-
Мекемелер:
- Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences
- Шығарылым: Том 69, № 1 (2024)
- Беттер: 90-102
- Бөлім: Cell biophysics
- URL: https://journals.rcsi.science/0006-3029/article/view/257128
- DOI: https://doi.org/10.31857/S0006302924010091
- EDN: https://elibrary.ru/RCSHTH
- ID: 257128
Дәйексөз келтіру
Аннотация
Авторлар туралы
R. Krestinin
Institute of Theoretical and Experimental Biophysics, Russian Academy of SciencesInstitutskaya ul. 3, Pushchino, Moscow Region, 142290, Russia
Yu. Baburina
Institute of Theoretical and Experimental Biophysics, Russian Academy of SciencesInstitutskaya ul. 3, Pushchino, Moscow Region, 142290, Russia
I. Odinokova
Institute of Theoretical and Experimental Biophysics, Russian Academy of SciencesInstitutskaya ul. 3, Pushchino, Moscow Region, 142290, Russia
L. Sotnikova
Institute of Theoretical and Experimental Biophysics, Russian Academy of SciencesInstitutskaya ul. 3, Pushchino, Moscow Region, 142290, Russia
О. Krestinina
Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences
Email: ovkres@mail.ru
Institutskaya ul. 3, Pushchino, Moscow Region, 142290, Russia
Әдебиет тізімі
- Havakuk O., King K. S., Grazette L., Yoon A. J., Fong M., Bregman N., Elkayam U., and Kloner R. A. Heart FailureInduced Brain Injury. J. Am. Coll. Cardiol., 69, 1609–1616 (2017). DOI: 10.1016/ j.jacc.2017.01.022
- Mueller K., Thiel F., Beutner F., Teren A., Frisch S., Ballarini T., Moller H. E., Ihle K., Thiery J., Schuler G., Villringer A., and Schroeter M. L. Brain Damage With Heart Failure: Cardiac Biomarker Alterations and Gray Matter Decline. Circ. Res., 126, 750– 764 (2020). doi: 10.1161/CIRCRESAHA.119.315813
- Rezin G. T., Amboni G., Zugno A. I., Quevedo J., and Streck E. L. Mitochondrial dysfunction and psychiatric disorders. Neurochem. Res., 34, 1021–1029 (2009). doi: 10.1007/s1106400898658
- Bhatti J. S., Bhatti G. K., and Reddy P. H. Mitochondrial dysfunction and oxidative stress in metabolic disorders – A step towards mitochondria based therapeutic strategies. Biochim. Biophys. Acta – Mol. Basis Dis., 1863, 1066–1077 (2017). doi: 10.1016/j.bbadis.2016.11.010
- Halliwell B. How to characterize an antioxidant: an update. Biochem. Soc. Symp., 61, 73–101 (1995). doi: 10.1042/bss0610073
- Regnier P., Bastias J., RodriguezRuiz V., CaballeroCasero N., Caballo C., Sicilia D., Fuentes A., Maire M., Crepin M., Letourneur D., Gueguen V., Rubio S., and PavonDjavid G. Astaxanthin from Haematococcus pluvialis Prevents Oxidative Stress on Human Endothelial Cells without Toxicity. Mar. Drugs, 13, 2857–2874 (2015). doi: 10.3390/md13052857
- HigueraCiapara I., FelixValenzuela L., and Goycoolea F. M. Astaxanthin: a review of its chemistry and applications. Crit. Rev. Food Sci. Nutr., 46, 185–196 (2006). doi: 10.1080/10408690590957188
- Kim S. H. and Kim H. Inhibitory Effect of Astaxanthin on Oxidative StressInduced Mitochondrial Dysfunction – A MiniReview. Nutrients, 10 (9), 1137 (2018) doi: 10.3390/nu10091137
- Baburina Y., Krestinin R., Odinokova I., Sotnikova L., Kruglov A., and Krestinina O. Astaxanthin Inhibits Mitochondrial Permeability Transition Pore Opening in Rat Heart Mitochondria. Antioxidants (Basel), 8, 576 (2019). doi: 10.3390/antiox8120576
- Krestinin R., Baburina Y., Odinokova I., Kruglov A., Fadeeva I., Zvyagina A., Sotnikova L., and Krestinina O. IsoproterenolInduced Permeability Transition PoreRelated Dysfunction of Heart Mitochondria Is Attenuated by Astaxanthin. Biomedicines, 8 (10), 437 (2020). doi: 10.3390/biomedicines8100437
- KrestininaO.,BaburinaY.,KrestininR.,OdinokovaI., Fadeeva I., and Sotnikova L. Astaxanthin Prevents Mitochondrial Impairment Induced by Isoproterenol in Isolated Rat Heart Mitochondria. Antioxidants (Basel), 9, 262 (2020). doi: 10.3390/antiox9030262
- Galasso C., Orefice I., Pellone P., Cirino P., Miele R., Ianora A., Brunet C., and Sansone C. On the Neuroprotective Role of Astaxanthin: New Perspectives? Mar. Drugs, 16, 247 (2018). doi: 10.3390/md16080247
- Akila P., Asaikumar L., and Vennila L. Chlorogenic acid ameliorates isoproterenolinduced myocardial injury in rats by stabilizing mitochondrial and lysosomal enzymes. Biomed. Pharmacother., 85, 582–591 (2017). doi: 10.1016/j.biopha.2016.11.067
- Twig G. and Shirihai O. S. The interplay between mitochondrial dynamics and mitophagy. Antioxid Redox Signal., 14, 1939–1951 (2011). DOI: 10.1089/ ars.2010.3779
- Cribbs J. T. and Strack S. Reversible phosphorylation of Drp1 by cyclic AMPdependent protein kinase and calcineurin regulates mitochondrial fission and cell death. EMBO Rep., 8, 939–944 (2007). doi: 10.1038/sj.embor.7401062
- Zhao X. Y., Lu M. H., Yuan D. J., Xu D. E., Yao P. P., Ji W. L., Chen H., Liu W. L., Yan C. X., Xia Y. Y., Li S., Tao J., and Ma Q. H. Mitochondrial Dysfunction in Neural Injury. Front. Neurosci., 13, 30 (2019). doi: 10.3389/fnins.2019.00030
- Taylor R. and Goldman S. J. Mitophagy and disease: new avenues for pharmacological intervention. Curr. Pharm. Des., 17, 2056–2073 (2011). doi: 10.2174/138161211796904768
- Ding W. X. and Yin X. M. Mitophagy: mechanisms, pathophysiological roles, and analysis. Biol. Chem., 393, 547–564 (2012). doi: 10.1515/hsz20120119
- Jin M., Liu X., and Klionsky D. J. SnapShot: Selective autophagy. Cell, 152, 368–368 (2013). e362, doi: 10.1016/j.cell.2013.01.004
- Mijaljica D., Prescott M., and Devenish R. Mitophagy: An Overview. In Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging, Ed. by M. A. Hayat (Acad. Press, 2014), pp. 103–116. doi: 10.1016/B9780124055285.000055
- Ambati R. R., Phang S. M., Ravi S., and Aswathanarayana R. G. Astaxanthin: sources, extraction, stability, biological activities and its commercial applicationsa review. Mar. Drugs, 12, 128–152 (2014). doi: 10.3390/md12010128
- Sims N. R. Rapid isolation of metabolically active mitochondria from rat brain and subregions using Percoll density gradient centrifugation. J. Neurochem., 55, 698–707 (1990).
- Baburina Y. L., Gordeeva A. E., Moshkov D. A., Krestinina O. V., Azarashvili A. A., Odinokova I. V., and Azarashvili T. S. Interaction of myelin basic protein and 2',3'cyclic nucleotide phosphodiesterase with mitochondria. Biochemistry (Moscow), 79, 555–565 (2014). doi: 10.1134/S0006297914060091
- Azarashvili T., Grachev D., Krestinina O., EvtodienkoY., Yurkov I., Papadopoulos V., and Reiser G. The peripheral-type benzodiazepine receptor is involved in control of Ca2+-induced permeability transition pore opening in rat brain mitochondria. Cell Calcium, 42, 27–39 (2007). doi: 10.1016/j.ceca.2006.11.004
- Baburina Y., Azarashvili T., Grachev D., Krestinina O., Galvita A., Stricker R., and Reiser G. Mitochondrial 2', 3'-cyclic nucleotide 3'-phosphodiesterase (CNP) interacts with mPTP modulators and functional complexes (I-V) coupled with release of apoptotic factors. Neurochem. Int., 90, 46–55 (2015). doi: 10.1016/j.neuint. 2015.07.012
- Jha P., Wang X., and Auwerx J. Analysis of Mitochondrial Respiratory Chain Supercomplexes Using Blue Native Polyacrylamide Gel Electrophoresis (BNPAGE). Curr. Protoc. Mouse Biol., 6, 1–14 (2016). doi: 10.1002/9780470942390.mo150182
- Escobar-Henriques M. and Anton F. Mechanistic perspective of mitochondrial fusion: tubulation vs. fragmentation. Biochim. Biophys. Acta, 1833, 162–175 (2013). doi: 10.1016/j.bbamcr.2012.07.016
- Wei Y., Chiang W. C., Sumpter R., Jr., Mishra P., and Levine B. Prohibitin 2 Is an Inner Mitochondrial Membrane Mitophagy Receptor. Cell, 168, 224–238.E1–E6 (2017). doi: 10.1016/j.cell.2016.11.042
- Baburina Y., Krestinin R., Odinokova I., Fadeeva I., Sotnikova L., and Krestinina O. The Identification of Prohibitin in the Rat Heart Mitochondria in Heart Failure. Biomedicines, 9 (12), 1793 (2021). doi: 10.3390/biomedicines9121793
- Richards E. M., Li J., Stevens B. R., Pepine C. J., and Raizada M. K. Gut Microbiome and Neuroinf lammation in Hypertension. Circ. Res., 130, 401–417 (2022). doi: 10.1161/CIRCRESAHA.121.319816
- Kettenmann H., Hanisch U. K., Noda M., and Verkhratsky A. Physiology of microglia. Physiol. Rev., 91, 461–553 (2011). doi: 10.1152/physrev.00011.2010 Baburina Y., Krestinin R., Fedorov D., Odinokova I., Pershina E., Sotnikova L., and Krestinina O. The Improvement of Functional State of Brain Mitochondria with Astaxanthin in Rats after Heart Failure. Int. J. Mol. Sci., 24, 31 (2022). doi: 10.3390/ijms24010031
- Nishida Y., Nawaz A., Hecht K., and Tobe K. Astaxanthin as a Novel Mitochondrial Regulator: A New Aspect of Carotenoids, beyond Antioxidants. Nutrients, 14, 107 (2021). doi: 10.3390/nu14010107
- Kinnally K. W. and Antonsson B. A tale of two mitochondrial channels, MAC and PTP, in apoptosis. Apoptosis, 12, 857–868 (2007). doi: 10.1007/s10495-007-0722-z
- Kwong J. Q. and Molkentin J. D. Physiological and pathological roles of the mitochondrial permeability transition pore in the heart. Cell Metab., 21, 206–214 (2015). doi: 10.1016/j.cmet.2014.12.001
- Twig G., Elorza A., Molina A. J., Mohamed H., Wikstrom J. D., Walzer G., Stiles L., Haigh S. E., Katz S., Las G., Alroy J., Wu M., Py B. F., Yuan J., Deeney J. T., Corkey B. E., and Shirihai O. S. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J., 27, 433–446 (2008). doi: 10.1038/sj.emboj.7601963
- Hom J. and Sheu S. S. Morphological dynamics of mitochondriaa special emphasis on cardiac muscle cells. J. Mol. Cell. Cardiol., 46, 811–820 (2009). doi: 10.1016/j.yjmcc.2009.02.023
- Gazaryan I. G. and Brown A. M. Intersection between mitochondrial permeability pores and mitochondrial fusion/fission. Neurochem. Res., 32, 917–929 (2007). doi: 10.1007/s11064-006-9252-2
- Burte F., Carelli V., Chinnery P. F., and Yu-Wai-Man P. Disturbed mitochondrial dynamics and neurodegenerative disorders. Nat. Rev. Neurol., 11, 11–24 (2015). doi: 10.1038/nrneurol.2014.228
- Reddy P. H., Reddy T. P., Manczak M., Calkins M. J., Shirendeb U., and Mao P. Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases. Brain Res. Rev., 67, 103–118 (2011). doi: 10.1016/j.brainresrev.2010.11.004
- Cui M., Ding H., Chen F., Zhao Y., Yang Q., and Dong Q. Mdivi-1 Protects Against Ischemic Brain Injury via Elevating Extracellular Adenosine in a cAMP/CREB-CD39-Dependent Manner. Mol. Neurobiol., 53, 240-253 (2016). doi: 10.1007/s12035-014-9002-4
- Youle R. J. and van der Bliek A. M. Mitochondrial fission, fusion, and stress. Science, 337, 1062-1065 (2012). doi: 10.1126/science.1219855
- Li W., He P., Huang Y., Li Y. F., Lu J., Li M., Kurihara H., Luo Z., Meng T., Onishi M., Ma C., Jiang L., Hu Y., Gong Q., Zhu D., Xu Y., Liu R., Liu L., Yi C., Zhu Y., Ma N., Okamoto K., Xie Z., Liu J., He R.-R., and Feng D. Selective autophagy of intracellular organelles: recent research advances. Theranostics, 11, 222–256 (2021). doi: 10.7150/thno.49860
- Tatsuta T., Model K., and Langer T. Formation of membrane-bound ring complexes by prohibitins in mitochondria. Mol. Biol. Cell, 16, 248–259 (2005). doi: 10.1091/mbc.e04-09-0807 45. Yan C., Gong L., Chen L., Xu M., Abou-Hamdan H., Tang M., Desaubry L., and Song Z. PHB2 (prohibitin 2) promotes PINK1-PRKN/Parkin-dependent mitophagy by the PARL-PGAM5-PINK1 axis. Autophagy, 16, 419–434 (2020). doi: 10.1080/15548627.2019.1628520
- Yan C., Gong L., Chen L., Xu M., Abou-Hamdan H., Tang M., Desaubry L., and Song Z. PHB2 (prohibitin 2) promotes PINK1-PRKN/Parkin-dependent mitophagy by the PARL-PGAM5-PINK1 axis. Autophagy, 16, 419–434 (2020). doi: 10.1080/15548627.2019.1628520